Jan A. De Jonge

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Identification of the plant mitochondrial OrfX protein: A mass spectrometry approach.

Identification of the plant mitochondrial OrfX protein: A mass spectrometry approach.

Journal: FEBS letters
Published: June 05, 2026

VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal Cavity.

VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal Cavity.

Journal: European journal of immunology
Published: January 15, 2025

Staff outcomes and the work environment in Green Care Farms and traditional nursing homes: A comparative study.

Staff outcomes and the work environment in Green Care Farms and traditional nursing homes: A comparative study.

Journal: International journal of nursing studies
Published: September 20, 2024

"Are you feeling safe?": an investigation of psychosocial safety climate in the relations of job characteristics and employee exhaustion and engagement.

"Are you feeling safe?": an investigation of psychosocial safety climate in the relations of job characteristics and employee exhaustion and engagement.

Journal: Industrial health
Published: May 19, 2024

A phase I dose-escalation study of LRP5/6 antagonist BI 905677 in patients with advanced solid tumors.

A phase I dose-escalation study of LRP5/6 antagonist BI 905677 in patients with advanced solid tumors.

Journal: ESMO open
Published: April 18, 2024

Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab - study protocol.

Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab - study protocol.

Journal: BMC cancer
Published: January 30, 2024

Managing Vitality, Sustainable Performance and Fatigue in Nursing Home Staff: A Multi-Location Cross-Sectional Survey Study: Empirical Research Quantitative.

Managing Vitality, Sustainable Performance and Fatigue in Nursing Home Staff: A Multi-Location Cross-Sectional Survey Study: Empirical Research Quantitative.

Journal: Nursing open
Published: January 24, 2024

Prevalence of High-Risk HPV Subtypes and Efficacy of the HPV Vaccine in Preventing Cervical Epithelial Lesions: Survey and Insights from a German Study.

Prevalence of High-Risk HPV Subtypes and Efficacy of the HPV Vaccine in Preventing Cervical Epithelial Lesions: Survey and Insights from a German Study.

Journal: Life (Basel, Switzerland)
Published: June 27, 2023

Distribution and incidence of atypical glandular lesions in cervical cytology focusing on the association with high-risk human papillomavirus subtypes.

Distribution and incidence of atypical glandular lesions in cervical cytology focusing on the association with high-risk human papillomavirus subtypes.

Journal: Oncology letters
Published: July 19, 2022

HPV-genotyping versus conventional cervical cytology as a screening method to detect dysplastic cervical epithelial changes.

HPV-genotyping versus conventional cervical cytology as a screening method to detect dysplastic cervical epithelial changes.

Journal: Scientific reports
Published: July 05, 2022

The meaning of screening: detection of brain metastasis in the adjuvant setting for stage III melanoma.

The meaning of screening: detection of brain metastasis in the adjuvant setting for stage III melanoma.

Journal: ESMO open
Published: July 04, 2022

Evaluation of P16/Ki67 (CINtecPlus) and L1-capsid compared with HPV-genotyping in cervical cytology in women ≥35 years old focusing on patients with atypical squamous cells of undetermined significance.

Evaluation of P16/Ki67 (CINtecPlus) and L1-capsid compared with HPV-genotyping in cervical cytology in women ≥35 years old focusing on patients with atypical squamous cells of undetermined significance.

Journal: Oncology letters
Published: March 25, 2022
Showing 1-12 of 37

Last Updated: 09/26/2026